Nascent Biotech Ratios and Metrics

Market cap in millions USD. Fiscal year is April - March.

Millions USD. Fiscal year is Apr - Mar.

Year Ending	Current	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022	Mar 31, 2021	Mar 31, 2020	2018 - 2013
Market Capitalization	9	31	7	6	6	12	Upgrade
Market Cap Growth	337.22%	337.22%	13.54%	-0.40%	-47.12%	122.34%	Upgrade
Enterprise Value	8	31	7	6	6	12	Upgrade
Last Close Price	0.18	0.18	0.06	0.06	0.06	0.27	Upgrade
PE Ratio	-	-13.76	-2.38	-13.06	-4.68	-2.30	Upgrade
PS Ratio	-	-	-	6.31	8.44	-	Upgrade
PB Ratio	-122.00	-122.00	-5.53	-9.39	-13.40	-4.16	Upgrade
P/FCF Ratio	-26.40	-26.40	-4.01	15.26	-6.42	-21.61	Upgrade
P/OCF Ratio	-26.40	-26.40	-4.01	15.26	-6.42	-21.61	Upgrade
EV/Sales Ratio	-	-	-	6.47	8.52	-	Upgrade
EV/EBIT Ratio	-13.82	-13.82	-3.28	-14.16	-4.56	-3.47	Upgrade
EV/FCF Ratio	-25.98	-25.98	-3.96	15.65	-6.47	-21.60	Upgrade
Debt / Equity Ratio	-0.48	-0.48	-0.30	-	-0.34	-0.05	Upgrade
Debt / FCF Ratio	-0.10	-0.10	-0.22	-	-0.16	-0.25	Upgrade
Asset Turnover	-	-	-	2.33	1.99	-	Upgrade
Quick Ratio	0.46	0.46	0.11	0.12	0.61	0.00	Upgrade
Current Ratio	0.68	0.68	0.16	0.14	0.61	0.00	Upgrade
Return on Assets (ROA)	-345.34%	-345.34%	-747.66%	-66.68%	-231.96%	-3199.30%	Upgrade
Earnings Yield	-24.25%	-6.67%	-39.11%	-7.46%	-15.14%	-33.43%	Upgrade
FCF Yield	-13.78%	-3.79%	-24.95%	6.55%	-15.58%	-4.63%	Upgrade
Buyback Yield / Dilution	-29.47%	-31.35%	-10.05%	-48.93%	-110.34%	-14.30%	Upgrade
Total Shareholder Return	-29.47%	-31.35%	-10.05%	-48.93%	-110.34%	-14.30%	Upgrade

Source: S&P Capital IQ. Standard template.